Summary
Substances that cause contraction or relaxation of smooth muscle have been shown to increase intracellular levels of cyclic GMP. Because of the unclear role of cyclic GMP in the control of smooth muscle tone, cyclic GMP derivatives were exogenously applied to various smooth muscle preparations and their effects on tissue tone were studied.
Whereas the basal tone of the rat ductus deferens was not affected by exogenous cyclic GMP or its dibutyryl or 8-bromo derivatives, the contractile responses of this tissue to noradrenaline and acetylcholine were depressed by preincubation with 10 μM 8-bromo cyclic GMP (Br-cGMP). The 8-bromo derivatives of 2′:3′-cyclic GMP, 5′-GMP and guanosine were without effects. Cyclic AMP levels were not changed by Br-cGMP. The frequency of oxytocin-stimulated rat uteri was also depressed by Br-cGMP (10 μM). In helical strips of rat and rabbit aortae, Br-cGMP (1–100 μM) caused a concentration-dependent, rapid decrease in noradrenaline-stimulated tissue tension. Br-2′:3′-cyclic GMP was ineffective. Noradrenaline-stimulated strips from hog spleen arteries were less sensitive to Br-cGMP than aortic tissue. In ductus deferentes and aortic strips stimulated by K+ at a depolarizing concentration, Br-cGMP caused less relaxation than under hormonal stimulation.
These findings support the concept that cyclic GMP is involved in the control of smooth muscle tone and that hormone- and drug-induced elevations of the cyclic GMP level can reduce contractile responses to neurotransmitters and hormones.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- cGMP:
-
Guanosine 3′:5′-monophosphate, cyclic GMP
- dibutyryl cGMP:
-
N2, 2′-O-dibutyryl guanosine 3′:5′-monophosphate
- Br-cGMP:
-
8-bromo guanosine 3′:5′-monophosphate
- Br-2′:3′-cGMP:
-
8-bromo guanosine 2′:3′-monophosphate
- Br-GMP:
-
8-bromo guanosine 5′-monophosphate
- Br-Guo:
-
8-bromo guanosine, Br-guanosine
- cAMP:
-
adenosine 3′:5′-monophosphate, cyclic AMP
- dibutyryl cAMP:
-
N6, 2′-O-dibutyryl adenosine 3′:5′-monophosphate
- Br-cAMP:
-
8-bromo adenosine 3′:5′-monophosphate
References
Andersson, R., Nilsson, K., Wikberg, J., Johansson, S., Mohme-Lundholm, E., Lundholm, L.: Cyclic nucleotides and the contraction of smooth muscle. Adv. Cycl. Nucl. Res. 5, 491–518 (1975)
Arnold, W. P., Mittal, C. K., Katsuki, S., Murad, F.: Nitric oxid activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparation. Proc. Natl. Acad. Sci. U.S.A. 74, 3203–3207 (1977)
Bär, H.-P.: Cyclic nucleotides and smooth muscle. Adv. Cycl. Nucl. Res. 4, 195–237 (1974)
Baudoin-Legros, M., Meyer, P.: Effects of angiotensin, catecholamines and cyclic AMP on calcium storage in aortic microsomes. Brit. J. Pharmacol. 47, 377–385 (1973)
Berridge, M. J., Lipke, H.: Changes in calcium transport across Calliphora salivary glands induced by 5-hydroxytryptamine and cyclic nucleotides. J. Exp. Biol. in press (1978)
Bhalla, R. C., Webb, R. C., Singh, D., Brock, T.: Role of cyclic AMP in aortic microsomal phosphorylation and calcium uptake. Amer. J. Physiol. 234, H 508–514 (1978)
Böhme, E., Graf, H., Schultz, G.: Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv. Cycl. Nucl. Res. 9, 131–143 (1978)
Casnellie, J. E., Greengard, P.: Guanosine 3′:5′-cyclic monophosphate-dependent phosphorylation of endogenous substrate proteins in membranes of mammalian smooth muscle. Proc. Natl. Acad. Sci. U.S.A. 71, 1891–1895 (1974)
Chantot, J.-F., Guschlbauer, W.: Physiochemical properties of nucleotides. FEBS Letters 4, 173–176 (1969)
Diamond, J.: Role of cyclic nucleotides in control of smooth muscle contraction. Adv. Cycl. Nucl. Res. 9, 327–340 (1978)
Diamond, J., Blisard, K. S.: Effects of stimulant and relaxant drugs on tension and cyclic nucleotide levels in canine femoral artery. Molec. Pharmacol. 12, 688–692 (1976)
Diamond, J., Holmes, T. G.: Effects of potassium chloride and smooth muscle relaxants on tension and cyclic nucleotide levels in rat myometrium. Canad. J. Physiol. Pharmacol. 53, 1099–1107 (1975)
Dunham, E. W., Haddox, M. K., Goldberg, N. D.: Alteration of vein cyclic 3′:5′ nucleotide concentrations during change of contractility. Proc. Natl. Acad. Sci. U.S.A. 71, 815–819 (1974)
Fermum, R., Klinner, U., Meisel, P.: Versuche zum Wirkungsmechanismus von Gefäßspasmolytika. I. Wirkung von Nitroprussid-Natrium, Nitroglycerin, Prenylamin und Verapamil an der arretierten Kalium-induzierten Kontraktur isolierter Koronararterien. Acta Biol. Med. Germ. 35, 1347–1358 (1976)
Fitzpatrick, D. F., Szentivanyi, A.: Stimulation of calcium uptake into aortic microsomes by cyclic AMP and cyclic AMP-dependent protein kinase. Naunyn-Schmiedeberg's Arch. Pharmacol. 298, 255–257 (1977)
Fleckenstein, A., Grün, G., Tritthart, H., Byon, K., Harding, P.: Uterus-Relaxation durch hochaktive Ca2+-antagonistische Hemmstoffe der elektro-meachnischen Koppelung wie Isoptin (Verapamil, Iproveratril), Substanz D 600 und Segontin (Prenylamin). Klin. Wschr. 49, 32–41 (1971)
Goldberg, N. D., Haddox, M. K.: Cyclic GMP metabolism and involvement in biological regulation. Ann. Rev. Biochem. 46, 823–896 (1977)
Häusler, G., Thorens, S.: The pharmacology of vasoactive antihypertensives. In: Vascular neuroeffector mechanisms, J. A. Bevan, G. Burnstock, B. Johansson, R. A. Maxwell, O. A. Nedergard (eds.), pp. 232–241. Basel: Karger 1976
Heersche, J. N. M., Ferak, S. A., Aurbach, J. D.: The mode of action of dibutyryl adenosine 3′,5′-monophosphate in bone tissue in vitro. J. Biol. Chem. 246, 6770–6775 (1971)
Hurwitz, L., Suria, A.: The link between agonist and action and response in smooth muscle. Ann. Rev. Pharmacol. 11, 303–326 (1971)
Katsuki, S., Murad, F.: Regulation of adenosine cyclic 3′:5′-monophosphate and guanosine cyclic 3′:5′-monophosphate levels and contractility in bovine tracheal smooth muscle. Molec. Pharmacol. 13, 330–341 (1977).
Kreye, V. A. W., Lüth, J. B.: Effect of sodium nitroprusside, temperature, and calcium withdrawal on the relaxation speed of vascular smooth muscle. In: Ionic actions on vascular smooth muscle (E. Betz, ed.), pp. 145–149. Berlin-Heidelberg-New York: Springer 1976
Kreye, V. A. W., Schultz, G.: Inhibition of norepinephrine-, angiotensin II-, and vasopressin-induced contractions of smooth muscle by acyl derivatives of adenosine-3′:5′-monophosphate. Europ. J. Pharmacol. 18, 297–302 (1972)
Kreye, V. A. W., Baron, G. D., Lüth, J. B., Schmidt-Gayk, H.: Mode of action of sodium nitroprusside on vascular smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 381–402 (1975)
Kreye, V. A. W., Kern, R., Schleich, I.: 36Chloride efflux from noradrenaline-stimulated rabbit aorta inhibited by sodium nitroprusside and nitroglycerine. In: Excitation-contraction coupling in smooth muscle, R. Casteels, T. Godfraind, J. C. Rüegg (eds.), pp. 145–150. Amsterdam-New York: Elsevier/North Holland 1977
Kuo, J. F., Shoji, M., Kuo, W. N.: Molecular and physiopathologic aspects of mammalian cyclic GMP-dependent protein kinase. Ann. Rev. Pharmacol. 18, 341–355 (1978)
Lee, T.-P., Kuo, J. F., Greengard, P.: Role of muscarinic cholinergic receptors in the regulation of guanosine 3′:5′-cyclic monophosphate content in mammalian brain, heart muscle and intestinal smooth muscle. Proc. Natl. Acad. Sci. U.S.A. 69, 3287–3291 (1972)
Lewis, A. J., Douglas, J. S., Bouhuys, A.: Biphasic responses to guanosyl nucleotides in two smooth muscle preparations. J. Pharm. Pharmacol. 25, 1011–1013 (1973)
Lincoln, T. M., Corbin, J. D.: On the role of the cAMP and cGMP-dependent protein kinases in cell function. J. Cycl. Nucl. Res. 4, 3–14 (1978)
Michal, G., Mühlegger, K., Nelboeck, N., Thiessen, C., Weimann, G.: Cyclophosphates. VI. Cyclophosphates as substrates and effectors of phosphodiesterase. Pharmacol. Res. Comm. 6, 203–252 (1974)
Nilsson, K. B., Andersson, R. G. G.: Effects of carbachol and calcium on the cyclic guanosine-3′:5′-monophosphate (cyclic GMP) metabolism in intestinal smooth muscle. Acta Physiol. Scand. 99, 246–253 (1977)
Nishikori, K., Takenaka, T., Maeno, H.: Stimulation of microsomal calcium uptake and protein phosphorylation by adenosine cyclic 3′:5′-monophosphate in rat uterus. Molec. Pharmacol. 13, 671–678 (1977)
Puglisi, L., Berti, F., Paoletti, R.: Antagonism of dibutyryl Guo-3′:5′-P and atropine on stomach muscle contraction. Experientia 27, 1187–1188 (1971)
Robison, G. A., Butcher, R. W., Sutherland, E. W.: Cyclic AMP. New York-London: Academic Press 1971
Schultz, G.: Possible interrelations between calcium and cyclic nucleotides in smooth muscle. In: Asthma II. Physiology, immuno-pharmacology and treatment (L. M. Lichtenstein, K. F. Austen, eds.), pp. 77–89. New York-San Francisco-London: Academic Press 1977a
Schultz, G.: The role of cyclic GMP in the actions of hormones and drugs affecting smooth muscle tone. In: Hormones and cell regulation. Vol. 2. J. Dumont, J. Numez (eds.), pp. 107–117. Amsterdam-New York: Elsevier/North Holland 1978
Schultz, G., Hardman, J. G.: Possible roles of cyclic nucleotides in the regulation of smooth muscle tonus. In: Eukaryotic cell functions and growth, regulation by intracellular cyclic nucleotides. J. E. Dumont, B. L. Brown, N. J. Marshall (eds.), pp. 667–683. New York-London: Plenum Press 1976
Schultz, G., Hardman, J. G., Schultz, K., Baird, C. E., Sutherland, E. W.: The importance of calcium ions for the regulation of guanosine-3′:5′-monophosphate levels. Proc. Natl. Acad. Sci. U.S.A. 70, 3889–3893 (1973a)
Schultz, G., Hardman, J. G., Schultz, K., Davis, J. W., Sutherland, E. W.: A new enzymatic assay for guanosine 3′:5′-cyclic monophosphate and its application to the ductus deferens of the rat. Proc. Nat. Acad. Sci. U.S.A. 70, 1721–1725 (1973b)
Schultz, G., Schultz, K., Hardman, J. G.: Effects of norepinephrine on cyclic nucleotide levels in the ductus deferens of the rat. Metabolism 24, 429–437 (1975)
Schultz, K. D.: Effects of 8-Br-cGMP on the tonus of rat ductus deferens and aorta. Naunyn-Schmiedeberg's Arch. Pharmacol. 297, Suppl. II, R 12 (1977b)
Schultz, K. D., Schultz, K., Schultz, G.: Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature 265, 750–751 (1977)
Schultz, G., Schultz, K. D., Böhme, E., Kreye, V. A. W.: The possible role of cyclic GMP in the actions of hormones and drugs on smooth muscle tone: Effects of exogenous cyclic GMP derivatives. Proc. 7th Intern. Congr. Pharmacol. Paris 1978, New York-London: Pergamon Press (in press)
Somlyo, A. P., Somlyo, A. V.: Vascular smooth muscle. II. Pharmacology of normal and hypertensive vessels. Pharmacol. Rev. 22, 249–252 (1970)
Szaduykis-Szadurski, L., Berti, F.: Smooth muscle relaxing activity of 8-bromo-guanosine-3′:5′-monophosphate. Pharmacol. Res. Commun. 4, 53–61 (1972a)
Szaduykis-Szadurski, L., Weimann, G., Berti, F.: Pharmacological effects of cyclic nucleotides and their derivatives on tracheal smooth muscle. Pharmacol. Res. Comm. 4, 63–69 (1972b)
Takayanagi, I., Takagi, K.: The action of dibutyryl cyclic GMP (N2-2-O-dibutyryl cyclic guanosine-3′,5′-monophosphate) on the ileum of guinea pig. Jap. J. Pharmacol. 23, 573–575 (1973)
Wallach, D., Davies, P. J. A., Pastan, I.: Cyclic AMP-dependent phosphorylation of filamin in mammalian smooth muscle. J. Biol. Chem. 253, 4739–4745 (1978)
Wikberg, J. E. S., Andersson, R. G. G.: A promoting action of cyclic GMP on contractions of guinea vas deferens. Experientia 34, 737–739 (1978)
Zsotér, T. T., Henein, N. F., Wolinsky, C.: The effect of sodium nitroprusside on the uptake and efflux of 45Ca from rabbit and rat vessels. Europ. J. Pharmacol. 45, 7–12 (1977)
Author information
Authors and Affiliations
Additional information
This work was supported by grants from the Deutsche Forschungsgemeinschaft. Preliminary reports were presented (Schultz, 1977b; Schultz et al., 1978).
Rights and permissions
About this article
Cite this article
Schultz, KD., Böhme, E., Kreye, V.A.W. et al. Relaxation of hormonally stimulated smooth muscular tissues by the 8-bromo derivative of cyclic GMP. Naunyn-Schmiedeberg's Arch. Pharmacol. 306, 1–9 (1979). https://doi.org/10.1007/BF00515586
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00515586